Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.03 +0.26 (+0.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Non-Current Debt (2021 - 2025)

Updated

Analysis

Amylyx Pharmaceuticals (AMLX) Non-Current Debt (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 Amylyx Pharmaceuticals 3.24 Bn 2.05 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -375,000.00
Sep 30, 2025 191.11 Mn
Mar 31, 2025 65.58 Mn
Mar 31, 2021 26.16 Mn
API Access

Amylyx Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=AMLX&period=max&api_key=YOUR_API_KEY